Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
GigaCloud Technology Inc Announces Fourth Quarter and Year Ended December 31, 2024 Financial Results
EL MONTE, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- GigaCloud Technology Inc (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B ecommerce technology solutions for...
-
CALGARY, Alberta, March 03, 2025 (GLOBE NEWSWIRE) -- Vesta Properties (Vesta) is unveiling Broadway on 17th (Broadway), a landmark 47-storey residential development set to redefine Calgary’s...
-
RALEIGH, N.C., March 03, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, is pleased to announce that the U.S. Food and Drug Administration (FDA) has implemented significant labeling changes for...
-
NEW YORK, March 03, 2025 (GLOBE NEWSWIRE) -- Cove Capital LLC (“Cove” or the “Company”) and JSC Qazgeology, Kazakhstan’s national geological exploration company, and a wholly-owned subsidiary of JSC...
-
NEW YORK, March 03, 2025 (GLOBE NEWSWIRE) -- Rezolve Ai (NASDAQ: RZLV), a pioneer in AI-driven payment and engagement solutions, welcomes President Donald Trump’s landmark announcement designating...
-
NEW YORK, March 03, 2025 (GLOBE NEWSWIRE) -- SL Green Realty Corp. (NYSE: SLG), Manhattan’s largest office landlord, today announced it has signed a fifteen-year, 144,418 square foot renewal and...
-
Data revealed high correlation between LINE-1 expression and retrotransposon (RT) burden, with variability across tumor types and genomic loci, demonstrating the potential for precision LINE-1...
-
Presented positive interim data through 52 weeks and beyond for 4D-150 in wet AMD from PRISM Phase 1/2 clinical trial highlighting robust and durable clinical activity across diverse patient...
-
Blaqclouds Announces Major Milestones for March 2025
-
PITTSBURGH, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today welcomed the European Medicines Agency's...